A detailed history of Whittier Trust CO transactions in Pfizer Inc stock. As of the latest transaction made, Whittier Trust CO holds 206,639 shares of PFE stock, worth $5.45 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
206,639
Previous 238,129 13.22%
Holding current value
$5.45 Million
Previous $6.66 Million 10.24%
% of portfolio
0.08%
Previous 0.1%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

SELL
$27.7 - $31.39 $872,273 - $988,471
-31,490 Reduced 13.22%
206,639 $5.98 Million
Q2 2024

Jul 26, 2024

SELL
$25.26 - $29.6 $6.19 Million - $7.26 Million
-245,238 Reduced 50.74%
238,129 $6.66 Million
Q1 2024

May 02, 2024

BUY
$25.89 - $29.73 $277,773 - $318,973
10,729 Added 2.27%
483,367 $13.4 Million
Q4 2023

Jan 11, 2024

SELL
$26.13 - $33.94 $1.14 Million - $1.48 Million
-43,584 Reduced 8.44%
472,638 $13.6 Million
Q3 2023

Oct 27, 2023

BUY
$32.09 - $37.51 $75,154 - $87,848
2,342 Added 0.46%
516,222 $17.1 Million
Q2 2023

Jul 24, 2023

SELL
$36.12 - $41.79 $406,783 - $470,638
-11,262 Reduced 2.14%
513,880 $18.8 Million
Q1 2023

Apr 21, 2023

BUY
$39.39 - $51.28 $49,434 - $64,356
1,255 Added 0.24%
525,142 $21.4 Million
Q4 2022

Jan 25, 2023

BUY
$41.75 - $54.5 $51,352 - $67,035
1,230 Added 0.24%
523,887 $0
Q3 2022

Oct 21, 2022

BUY
$43.76 - $53.42 $263,916 - $322,176
6,031 Added 1.17%
522,657 $22.9 Million
Q2 2022

Jul 28, 2022

BUY
$46.53 - $55.17 $329,711 - $390,934
7,086 Added 1.39%
516,626 $27.1 Million
Q1 2022

Apr 29, 2022

BUY
$45.75 - $56.69 $268,735 - $332,997
5,874 Added 1.17%
509,540 $26.4 Million
Q4 2021

Jan 19, 2022

BUY
$41.32 - $61.25 $232,920 - $345,266
5,637 Added 1.13%
503,666 $29.7 Million
Q3 2021

Nov 01, 2021

SELL
$39.25 - $50.42 $92,159 - $118,386
-2,348 Reduced 0.47%
498,029 $21.4 Million
Q2 2021

Jul 29, 2021

BUY
$35.91 - $40.68 $146,548 - $166,015
4,081 Added 0.82%
500,377 $19.6 Million
Q1 2021

Apr 26, 2021

BUY
$33.49 - $37.77 $219,593 - $247,657
6,557 Added 1.34%
496,296 $18 Million
Q4 2020

Jan 29, 2021

BUY
$33.47 - $42.56 $170,094 - $216,289
5,082 Added 1.05%
489,739 $18 Million
Q3 2020

Oct 30, 2020

BUY
$31.75 - $37.25 $123,888 - $145,349
3,902 Added 0.81%
484,657 $17.8 Million
Q2 2020

Jul 10, 2020

SELL
$30.12 - $36.54 $2.37 Million - $2.87 Million
-78,633 Reduced 14.06%
480,755 $15.7 Million
Q1 2020

Apr 27, 2020

SELL
$27.03 - $38.62 $235,836 - $336,959
-8,725 Reduced 1.54%
559,388 $18.3 Million
Q4 2019

Jan 31, 2020

SELL
$32.92 - $37.36 $125,425 - $142,341
-3,810 Reduced 0.67%
568,113 $22.3 Million
Q3 2019

Oct 18, 2019

BUY
$32.49 - $42.13 $458,921 - $595,086
14,125 Added 2.53%
571,923 $20.5 Million
Q2 2019

Jul 23, 2019

BUY
$36.98 - $41.52 $242,551 - $272,329
6,559 Added 1.19%
557,798 $24.2 Million
Q1 2019

Apr 29, 2019

SELL
$37.5 - $41.2 $3.69 Million - $4.06 Million
-98,489 Reduced 15.16%
551,239 $23.4 Million
Q4 2018

Feb 07, 2019

BUY
$38.47 - $43.86 $173,230 - $197,501
4,503 Added 0.7%
649,728 $28.4 Million
Q3 2018

Oct 23, 2018

SELL
$34.47 - $41.81 $438,665 - $532,074
-12,726 Reduced 1.93%
645,225 $28.4 Million
Q2 2018

Jul 27, 2018

SELL
$32.98 - $35.16 $2.21 Million - $2.36 Million
-67,095 Reduced 9.25%
657,951 $23.9 Million
Q2 2018

Jul 20, 2018

BUY
$32.98 - $35.16 $1.58 Million - $1.68 Million
47,783 Added 7.06%
725,046 $21.5 Million
Q1 2018

May 01, 2018

SELL
$31.91 - $37.02 $1.1 Million - $1.28 Million
-34,550 Reduced 4.85%
677,263 $24 Million
Q4 2017

Feb 07, 2018

SELL
$33.26 - $35.29 $1.09 Million - $1.16 Million
-32,828 Reduced 4.41%
711,813 $25.8 Million
Q3 2017

Oct 23, 2017

BUY
$31.0 - $34.15 $23.1 Million - $25.4 Million
744,641
744,641 $26.6 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $148B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Whittier Trust CO Portfolio

Follow Whittier Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Whittier Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Whittier Trust CO with notifications on news.